Bioactive compounds from marine resources against novel corona virus (2019-nCoV): <i>in silico</i> study for corona viral drug
R. Vijayaraj, K. Altaff, A. Sherlin Rosita, S. Ramadevi, J. Revathy
Abstract
, has the strongest interaction with the protease enzyme of 2019-nCoV and it may be considered as an effective 2019-nCoV antiprotease drug.[Figure: see text].
Topics & Concepts
PubChemAutoDockProtein Data Bank (RCSB PDB)In silicoProteaseDocking (animal)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)Chemistry2019-20 coronavirus outbreakDrugDrug discoveryEnzymeVirologyBiologyStereochemistryBiochemistryPharmacologyMedicineInfectious disease (medical specialty)PathologyGeneNursingDiseaseOutbreakComputational Drug Discovery MethodsDiverse Scientific Research Studies